Recurrent pregnancy loss at gynecology and obstetrical hospital in Duhok Province


  • Iman Jaafar Abdulrahman Department of Obstetrics and Gynecology, Azadi Teaching Hospital, Iraqi Kurdistan, Duhok
  • Ariana Khalis Jawad Department of Obstetrics and Gynecology, College of Medicine, Erbil Medical University, Kurdistan, Iraq
  • Nasreen Abdulghafor SH. M. Amin Department of Obstetrics and Gynecology, Duhok Maternity Hospital, Iraqi Kurdistan, Duhok



Iatrogenic conditions, Maternal complications, Recurrent pregnancy loss


Background: Recurrent pregnancy loss is physically and emotionally harmful for mothers. This study aimed to find out the prevalence and associated factors of recurrent pregnancy loss (RPL) in pregnant women in Duhok province.

Methods: In this retrospective study, the medical records of the patients who had pregnancy loss and registered in Duhok Maternity Hospital were reviewed for the period of January - December 2019. Accordingly, 300 women aged 18 years and older with pregnancy loss were included in this study.

Results: The prevalence of EPL was 16.3%. The study found that patients with RPL were statistically older compared to those patients without RPL, (39.27 vs. 33.24 years; P<0.001), respectively. Besides, the RPL group had a significantly higher percentage of family history of pregnancy loss (12.24% vs. 1.20%; P<0.001). The patients with RPL had significantly higher prevalence of Chlamydia trachomatis (14.29% vs. 3.59%; P=0.002), cervical incompetence (8.16% vs. 0.80%; P=0.002), structural abnormalities of uterus (14.29% vs. 4.8%; P=0.012), and polycystic ovary syndrome (PCOS) (40.82% vs. 11.95%; P<0.001). There was no significant association of RPL with smoking (P=0.261).

Conclusions: This study revealed a high prevalence of RPL in patients with pregnancy loss. Also, the study showed that the patients in the RPL group were significantly older and had a higher prevalence of medical illnesses; including chlamydia trachomatis, cervical incompetence, structural anomalies of the uterus, and polycystic ovarian syndrome.


Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss. Hum Reprod Update. 2002;8(4):333-43.

Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103-11.

Royal College of Obstetricians and Gynaecologists. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG. 2011;17:1-7.

Kolte A, Bernardi L, Christiansen O, Quenby S, Farquharson R, Goddijn M, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015;30(3):495-8.

American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001.(Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. Intern J Gynaecol Obstet: the official organ of the Inter Federation Gynaecol Obstet. 2002 Aug;78(2):179.

Stirrat GM. Recurrent miscarriage I: definition and epidemiology. The Lancet. 1990;336(8716):673-5.

World Health Organization. Republic of Iraq: Iraq Family Health Survey Report, 2006/7. Baghdad: WHO. 2007.

Rasmark Roepke E, Matthiesen L, Rylance R, Christiansen OB. Is the incidence of recurrent pregnancy loss increasing? A retrospective register‐based study in Sweden. Acta Obstet Gynecol Scand. 2017;96(11):1365-72.

Mayoclinic. Incompetent cervix; 2020. Available from:

NHS. Polycystic ovary syndrome NHS; 2019. Available from:

Akbay CA, Azo FM. Prevalence and risk factors of abortion among a sample of married women in Kurdistan Region of Iraq. Zanco J Med Sci. 2016;20(3):1424-32.

Rasheed T, Asmaa’B A-O, Abdul-Mohaymen N. High Expression of P53 protein in Recurrent Pregnancy Loss Could Play a Role in the Pathology. J Fac Med Baghdad. 2011;53(2):194-7.

Kadim OR, Al‑Khateeb SM, Humadi EH. The association of serum copper with ceruloplasmin and zinc with folic acid levels in recurrent pregnancy loss in Iraqi Women. Mustansiriya Med J. 2019;18(1):43-6.

Jassem RM, Jaber HK, Shani WS. Association between cytokine gene polymorphism and recurrent pregnancy loss among Basra province women. Inter J Micro Biology, Genetics Monocular Biol Res. 2016;2(2):1-8.

Hussein AA, Salman ST, Khashman BM. Frequency of Human Cytomegalovirus and Human Herpesvirus-1 Antigens in Product of Conceptus Tissues of Pregnant Women with Spontaneous Abortion. Iraqi JMS. 2017;15(1):94-102.

Murad MA, Eassa SH, Al-Saeed AT. Detection of toxoplasmosis among women with abortion using molecular and serological tests in duhok city. DMJ. 2016;10(2):56-68.

Andersen A-MN, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320(7251):1708-12.

Lund M, Kamper-Jørgensen M, Nielsen HS, Lidegaard Ø, Andersen A-MN, Christiansen OB. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success? Obstet Gynecol. 2012;119(1):37-43.

Lo W, Rai R, Hameed A, Brailsford SR, Al-Ghamdi AA, Regan L. The effect of body mass index on the outcome of pregnancy in women with recurrent miscarriage. J Family Community Med. 2012;19(3):167.

Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. The J Clin Endocrinol Metabol. 2015;100(3):911-9.

Lathi RB, Schust D. Recurrent pregnancy loss. Berek and Novak’s Gynecology, 15th edn. JS Berek (ed). Philadelphia, PA, Lippincott Williams & Wilkins. 2012:1190-232.

Summers PR. Microbiology relevant to recurrent miscarriage. Clinical Obstet Gynecol. 1994;37(3):722-9.




How to Cite

Abdulrahman, I. J., Jawad, A. K., & SH. M. Amin, N. A. (2020). Recurrent pregnancy loss at gynecology and obstetrical hospital in Duhok Province. International Journal of Research in Medical Sciences, 8(9), 3160–3164.



Original Research Articles